...
首页> 外文期刊>Regenerative medicine >Interview: commercial translation of cell-based therapies and regenerative medicine: learning by experience. Interview by William A. Haseltine.
【24h】

Interview: commercial translation of cell-based therapies and regenerative medicine: learning by experience. Interview by William A. Haseltine.

机译:面试:基于细胞的疗法和再生医学的商业翻译:通过经验学习。 William A. Haseltine的访谈。

获取原文
获取原文并翻译 | 示例
           

摘要

Dr Haseltine speaks to Emily Culme-Seymour, Assistant Commissioning Editor William A Haseltine, PhD has an active career in both Science and Business. He was a professor at Harvard Medical School and Harvard School of Public Health (MA, USA) from 1976 to 1993, where he was Founder and Chair of two academic research departments. He is well known for his pioneering work on cancer, HIV/AIDS and genomics. He has authored more than 200 manuscripts in peer-reviewed journals and is the author of several books. He is the founder of Human Genome Sciences, Inc. and served as the Chairman and CEO of the company until 2004. He is also the founder of several other successful biotechnology companies. William Haseltine is currently Chairman and President of ACCESS Health International, Inc., which supports access to affordable, high-quality health services in low, middle and high income countries, and Chairman of the Haseltine Foundation for Science and the Arts, which fosters a dialog between sciences and the arts. He is an Adjunct Professor at the Scripps Institute for Medical Research and the Institute of Chemical Engineering, the University of Mumbai, India. He is a member of the Advisory Board of the IE University, Madrid, the President's Council of the Cold Spring Harbor Laboratory, the Advisory Council for the Koch Institute of MIT, a member of the University Council Committee on technology transfer, Yale University, and is a Lifetime Governor of the New York Academy of Science (NY, USA). He is an honorary member of the Board of Trustees of the Brookings Institution, a member of the Board of Trustees of the Center for Emerging Markets of the Indian School of Business, a member of the Council on Foreign Relations, a member of the Board of AID for AIDS International, and a member of the Chairman's Circle of the Asia Society. He is a member of the Advisory Board of the Metropolitan Opera (NY, USA), the Chairman's Council of the Metropolitan Museum (NY, USA), the International Council of the Guggenheim Museum, the International Council of the Tate Modern, the Board of Directors of the Young Concert Artists, Inc. and the Youth Orchestra of the Americas.
机译:Haseltine博士与助理调试编辑William A Haseltine博士Emily Culme-Seymour进行了交谈,博士在科学和商业领域都非常活跃。 1976年至1993年,他是哈佛医学院和哈佛大学公共卫生学院(美国马萨诸塞州)的教授,是两个学术研究部门的创始人和主席。他在癌症,艾滋病毒/艾滋病和基因组学方面的开拓性工作而闻名。他已经在同行评审期刊上撰写了200多种手稿,并且是多本著作的作者。他是人类基因组科学有限公司(Human Genome Sciences,Inc.)的创始人,并一直担任该公司的董事长兼首席执行官直到2004年。他还是其他几家成功的生物技术公司的创始人。 William Haseltine目前是爱可信健康国际有限公司的董事长兼总裁,爱可信国际支持在低,中,高收入国家提供可负担的,高质量的健康服务,并且是Haseltine科学与艺术基金会的主席,该基金会致力于促进科学与艺术之间的对话。他是印度孟买大学斯克里普斯医学研究所和化学工程研究所的兼职教授。他是马德里IE大学顾问委员会的成员,冷泉港实验室总裁理事会,麻省理工学院科赫研究所的顾问理事会,耶鲁大学大学理事会技术转让委员会的成员以及是纽约科学院(美国纽约)的终身理事。他是布鲁金斯学会董事会的名誉成员,印度商学院新兴市场中心的董事会成员,对外关系委员会的成员,董事会的成员。艾滋病国际援助组织,亚洲学会主席圈子成员。他是大都会歌剧院顾问委员会(美国纽约州),大都会博物馆主席委员会(美国纽约州),古根海姆博物馆国际委员会,泰特现代美术馆国际委员会,青年音乐会艺术家公司和美洲青年乐队的董事。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号